BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28477683)

  • 1. Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients.
    Trentini A; Castellazzi M; Romani A; Squerzanti M; Baldi E; Caniatti ML; Pugliatti M; Granieri E; Fainardi E; Bellini T; Cervellati C
    J Neurol Sci; 2017 Jun; 377():133-136. PubMed ID: 28477683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum ferroxidase activity in patients with multiple sclerosis: a pilot study.
    Cervellati C; Romani A; Fainardi E; Trentini A; Squerzanti M; Baldi E; Caniatti ML; Granieri E; Bellini T; Castellazzi M
    In Vivo; 2014; 28(6):1197-200. PubMed ID: 25398823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis.
    Rentzos M; Cambouri C; Rombos A; Nikolaou C; Anagnostouli M; Tsoutsou A; Dimitrakopoulos A; Triantafyllou N; Vassilopoulos D
    J Neurol Sci; 2006 Feb; 241(1-2):25-9. PubMed ID: 16316662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
    Mouzaki A; Rodi M; Dimisianos N; Emmanuil A; Kalavrizioti D; Lagoudaki R; Grigoriadis NC; Papathanasopoulos P
    PLoS One; 2015; 10(8):e0135434. PubMed ID: 26317430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis.
    Fainardi E; Castellazzi M; Bellini T; Manfrinato MC; Baldi E; Casetta I; Paolino E; Granieri E; Dallocchio F
    Mult Scler; 2006 Jun; 12(3):294-301. PubMed ID: 16764342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid molecular demonstration of Chlamydia pneumoniae DNA is associated to clinical and brain magnetic resonance imaging activity in a subset of patients with relapsing-remitting multiple sclerosis.
    Contini C; Cultrera R; Seraceni S; Castellazzi M; Granieri E; Fainardi E
    Mult Scler; 2004 Aug; 10(4):360-9. PubMed ID: 15327030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and MRI disease activity in multiple sclerosis are associated with reciprocal fluctuations in serum and cerebrospinal fluid levels of soluble HLA class I molecules.
    Fainardi E; Granieri E; Tola MR; Melchiorri L; Vaghi L; Rizzo R; Castellazzi M; Ceruti S; Paolino E; Baricordi OR
    J Neuroimmunol; 2002 Dec; 133(1-2):151-9. PubMed ID: 12446018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings.
    Fainardi E; Rizzo R; Melchiorri L; Vaghi L; Castellazzi M; Marzola A; Govoni V; Paolino E; Tola MR; Granieri E; Baricordi OR
    J Neuroimmunol; 2003 Sep; 142(1-2):149-58. PubMed ID: 14512174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis.
    Fainardi E; Rizzo R; Melchiorri L; Castellazzi M; Paolino E; Tola MR; Granieri E; Baricordi OR
    Mult Scler; 2006 Feb; 12(1):2-12. PubMed ID: 16459714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus-specific antibody response in cerebrospinal fluid and serum of patients with multiple sclerosis.
    Castellazzi M; Tamborino C; Cani A; Negri E; Baldi E; Seraceni S; Tola MR; Granieri E; Contini C; Fainardi E
    Mult Scler; 2010 Jul; 16(7):883-7. PubMed ID: 20483883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF levels of soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing-remitting multiple sclerosis.
    Fainardi E; Rizzo R; Melchiorri L; Stignani M; Castellazzi M; Tamborino C; Paolino E; Tola MR; Granieri E; Baricordi OR
    Mult Scler; 2008 May; 14(4):446-54. PubMed ID: 18208868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble intercellular adhesion molecule-I (sICAM-I) in serum and cerebrospinal fluid of demyelinating diseases of the central and peripheral nervous system.
    Trojano M; Avolio C; Ruggieri M; De Robertis F; Giuliani F; Paolicelli D; Livrea P
    Mult Scler; 1998 Feb; 4(1):39-44. PubMed ID: 9532592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal production of Chlamydia pneumoniae-specific high-affinity antibodies is significantly associated to a subset of multiple sclerosis patients with progressive forms.
    Fainardi E; Castellazzi M; Casetta I; Cultrera R; Vaghi L; Granieri E; Contini C
    J Neurol Sci; 2004 Feb; 217(2):181-8. PubMed ID: 14706222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copper and ceruloplasmin dyshomeostasis in serum and cerebrospinal fluid of multiple sclerosis subjects.
    De Riccardis L; Buccolieri A; Muci M; Pitotti E; De Robertis F; Trianni G; Manno D; Maffia M
    Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1828-1838. PubMed ID: 29524632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased levels of IL-23 and osteopontin in serum and cerebrospinal fluid of multiple sclerosis patients.
    Wen SR; Liu GJ; Feng RN; Gong FC; Zhong H; Duan SR; Bi S
    J Neuroimmunol; 2012 Mar; 244(1-2):94-6. PubMed ID: 22329905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis.
    Maimone D; Gregory S; Arnason BG; Reder AT
    J Neuroimmunol; 1991 Apr; 32(1):67-74. PubMed ID: 2002092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis.
    Stampanoni Bassi M; Iezzi E; Marfia GA; Simonelli I; Musella A; Mandolesi G; Fresegna D; Pasqualetti P; Furlan R; Finardi A; Mataluni G; Landi D; Gilio L; Centonze D; Buttari F
    J Neuroinflammation; 2018 Apr; 15(1):108. PubMed ID: 29655371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis.
    Piazza F; DiFrancesco JC; Fusco ML; Corti D; Pirovano L; Frigeni B; Mattavelli L; Andreoni S; Frigo M; Ferrarese C; Tredici G; Cavaletti G
    J Neuroimmunol; 2010 Mar; 220(1-2):104-7. PubMed ID: 20149932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neurofilament protein light in multiple sclerosis].
    Zhang Y; Li X; Qiao J
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2745-9. PubMed ID: 18167263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gamma delta T cell distribution in cerebrospinal fluid and peripheral blood of patients with multiple sclerosis.
    Droogan AG; Crockard AD; Hawkins SA; McNeill TA
    J Neurol Sci; 1994 Nov; 126(2):172-7. PubMed ID: 7853024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.